The Society announced support for one new initiative and continued funding for two more.

The National Rosacea Society (NRS) has announced that it will contribute funding for one new study, continue funding for two ongoing studies, as part of its grant program to advance rosacea research. 

"Ongoing research into the pathologic processes of rosacea has enabled ever more therapies that can combat rosacea’s signs and symptoms,” said Dr. Julie Harper, president and owner of the Dermatology and Skin Care Center of Birmingham, in a news release. “This year’s study will investigate whether common skin-care practices may prevent these sophisticated treatments from reaching their intended targets.”

The new funding, in the amount of $15,000, will go towards backing the work of two Duke University researchers determining whether the presence of four widely used skin moisturizers may affect the effectiveness of two topical medications. For the ongoing studies, funding was granted to a University of California-Davis team to continue work looking at single-cell RNA sequencing to help better understand the role of each cell type in rosacea and the interconnected ways they interact. The other grant supported a study out of the University of California-San Diego looking at whether laser therapy has an effect on the microbiome of the skin, and how blood vessels may drive the disease process. 

The NRS research grants program has awarded more than $1.6 million to support 78 different studies, including research that has helped advance understanding and treatment in inflammatory processes that are a key underlying factor of rosacea, as well as studies into the genetics of rosacea, the rold of inflammation, changes to various aspects of the eye in ocular rosacea, and more.

To read more about the NRS and its grant program, visit rosacea.org